Literature DB >> 33161533

Delta-opioid receptor-mediated modulation of excitability of individual hippocampal neurons: mechanisms involved.

Lucia Moravcikova1, Roman Moravcik1,2, Daniela Jezova3, Lubica Lacinova1, Eliyahu Dremencov4.   

Abstract

BACKGROUND: Delta-opioid receptor (DOR)-mediated modulation of hippocampal neural networks is involved in emotions, cognition, and in pathophysiology and treatment of mood disorders. In this study, we examined the effects of DOR agonist (SNC80) and antagonist (naltrindole) on the excitability of individual hippocampal neurons.
METHODS: Primary neuronal cultures were prepared from hippocampi of newborn rats and cultivated in vitro for 8-14 days (DIV8-14). The effects of SNC80 naltrindole on evoked and spontaneous action potentials (APs) were measured at DIV8-9 and DIV13-14, respectively.
RESULTS: SNC80 (100 µM) potentiated spontaneous AP firing and stimulated sodium current; naltrindole had opposite effects. The stimulatory effect of 100 µM of SNC80 was revoked by pre-administration of 1 µM of naltrindole. SNC80 and naltrindole induced similar inhibitory effects on the evoked AP firing and on the calcium current. Further, SNC80 inhibited both peak and sustained potassium currents. Naltrindole had no effect on potassium currents.
CONCLUSION: We suggest that the effects of naltrindole and high concentration of SNC80 on the sodium currents are mediated via DORs and underlying the changes in spontaneous activity. The inhibitory effects of SNC80 on calcium and potassium currents might also be DOR-dependent; these currents might mediate SNC80 effect on the evoked AP firing. The inhibitory effects of naltrindole on calcium and of low doses of SNC80 on sodium currents might be however DOR independent. The behavioral effects of SNC80 and naltrindole, observed in previous studies, might be mediated, at least in part, via the modulatory effect of these ligands on the excitability of hippocampal neurons.

Entities:  

Keywords:  Calcium current; Naltrindole; Potassium current; SNC80; Sodium current

Year:  2020        PMID: 33161533     DOI: 10.1007/s43440-020-00183-2

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  60 in total

Review 1.  Opioid receptors.

Authors:  Maria Waldhoer; Selena E Bartlett; Jennifer L Whistler
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

2.  Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys.

Authors:  Richard M Allen; Arthur L Granger; Linda A Dykstra
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

3.  Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder.

Authors:  Matthew J Kempton; Zainab Salvador; Marcus R Munafò; John R Geddes; Andrew Simmons; Sophia Frangou; Steven C R Williams
Journal:  Arch Gen Psychiatry       Date:  2011-07

4.  Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist.

Authors:  S N Calderon; R B Rothman; F Porreca; J L Flippen-Anderson; R W McNutt; H Xu; L E Smith; E J Bilsky; P Davis; K C Rice
Journal:  J Med Chem       Date:  1994-07-08       Impact factor: 7.446

Review 5.  Functional neurogenesis over the years.

Authors:  Jason S Snyder; Michael R Drew
Journal:  Behav Brain Res       Date:  2020-01-07       Impact factor: 3.332

6.  A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80.

Authors:  Elizabeth L Gallantine; Theo F Meert
Journal:  Basic Clin Pharmacol Toxicol       Date:  2005-07       Impact factor: 4.080

7.  Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats.

Authors:  E M Jutkiewicz; K C Rice; J H Woods; P J Winsauer
Journal:  Behav Pharmacol       Date:  2003-11       Impact factor: 2.293

Review 8.  Non-peptidic δ opioid receptor agonists and antagonists (2000 - 2012).

Authors:  Hideaki Fujii; Toshihiro Takahashi; Hiroshi Nagase
Journal:  Expert Opin Ther Pat       Date:  2013-05-27       Impact factor: 6.674

9.  Neuroimaging of pain in animal models: a review of recent literature.

Authors:  Joyce T Da Silva; David A Seminowicz
Journal:  Pain Rep       Date:  2019-08-07

10.  A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks.

Authors:  Eric Erbs; Lauren Faget; Gregory Scherrer; Audrey Matifas; Dominique Filliol; Jean-Luc Vonesch; Marc Koch; Pascal Kessler; Didier Hentsch; Marie-Christine Birling; Manoussos Koutsourakis; Laurent Vasseur; Pierre Veinante; Brigitte L Kieffer; Dominique Massotte
Journal:  Brain Struct Funct       Date:  2014-03-13       Impact factor: 3.270

View more
  1 in total

1.  Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions.

Authors:  Arryn T Blaine; Yiming Miao; Jinling Yuan; Sophia Palant; Rebecca J Liu; Zhong-Yin Zhang; Richard M van Rijn
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.